NRAS Mutational Analysis (Colon and Rectum)
Data Item Details
Parent Schema: Colon and Rectum
NAACCR Item: #3941
NAACCR XML ID: nrasMutationalAnalysis
Organization Field Mapping
Organization | Field Name | ID# | ID Name | Required |
|---|---|---|---|---|
KCR | NRAS Mutational Analysis | 34129 | NrasMutationalAnalysis | yes |
SEER | NRAS Mutational Analysis | nrasMutationalAnalysis | yes |
Valid Values
Notes
Note 1 Effective years
This SSDI is effective for diagnosis years 2021+
For cases diagnosed 2018-2020, this SSDI must be blank
Note 2 Physician Statement
Physician statement of NRAS can be used to code this data item when no other information is available.
Note 3 Applicable stages
NRAS may be recorded for all stages; however, it is primarily performed for patients with metastatic disease. If information is not available, code 9.
Note 4 Results from nodal or metastatic tissue
Results from nodal or metastatic tissue may be used for NRAS.
Note 5 Neoadjuvant Therapy
Record the assay from tumor specimens prior to neoadjuvant therapy.
If neoadjuvant therapy is given and there are no NRAS results from pre-treatment specimens, report the findings from post-treatment specimens.
Code | Description |
|---|---|
0 | Normal |
1 | Abnormal (mutated)/detected in codon(s) 12, 13, and/or 61 |
2 | Abnormal (mutated)/detected, codon(s) specified but not in codon(s) 12, 13, or 61 |
4 | Abnormal (mutated), NOS, codon(s) not specified |
7 | Test ordered, results not in chart |
8 | Not applicable: Information not collected for this case |
9 | Not documented in medical record |
<BLANK> | Must be blank if diagnosis year is before 2021 |
For official definitions and additional context, refer to the NAACCR Data Dictionary.